Lemtrada Better At Preventing MS Relapses Than Rebif, But Did Not Reduce Disability
Although Lemtrada (alemtuzumab) was found to be more effective in preventing MS relapses than the older drug – Rebif – it did not reduce disability in a late-stage clinical trial, the study’s second primary endpoint. In previous studies it had, makers Sanofi and its subsidiary Genzyme announced today. The older drug, Rebif is marketed by Merck KGaA of Germany. Genzyme is developing alemtuzumab …
Read more on Medical News Today
July 18th, 2011 | Posted in Medication Natural | No Comments
Brazil’s Thiago Silva may play against Paraguay
Brazil defender Thiago Silva is improving from his right thigh injury and may be available to play against Paraguay in the quarterfinals of the Copa America on Sunday. Thiago Silva missed practice again on Saturday but Brazil doctor Rodrigo Lasmar says the AC Milan defender may recover in time for the decisive match in La Plata.
Read more on AP via Yahoo! Sports
July 18th, 2011 | Posted in Natural Doctor | No Comments
A closer look at the placebo effect
Study provides new insights into the placebo effect and suggests that in addition to active therapies, the idea of being cared for is important to patients’ health.
Read more on EurekAlert!
July 16th, 2011 | Posted in Medication Natural | No Comments
